CASP3 and atopic eczema: Although direct evidence for their activity in keratinocytes or atopic dermatitis is limited, their predicted targeting of CASP3 and PPARG suggests a role in fine-tuning apoptosis–lipid metabolism cross-talk, as well as in context-specific regulation of barrier repair pathways.